Promega - Articles and news items

Michael Bjerke, Global Product Manager, Detection, Promega

Promega interviewed at SLAS 2014

News, Supplier news, Videos / 29 January 2014 / Freddy White, European Pharmaceutical Review

Michael Bjerke, Promega’s Global Product Manager, Detection, speaks to Freddy White at SLAS 2014.

Practical Workshop – Biochemical Assays for Screening

Issue 1 2013 / 21 February 2013 / Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany

Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify chemical starting points that modify the functions of genes, cells or biochemical pathways. In some, but not all instances, these functions may be linked to disease processes, and an opportunity will exist to further develop the probes into novel therapeutic agents. In small molecule drug discovery, the ultimate aim is to identify new therapeutics, an activity which for reasons of high risk and cost has historically been conducted within the commercial sectors[4].

Tecan _ Freedom EVO

Tecan and Promega offer variable volume DNA isolation

News, Supplier news / 15 November 2012 / kdm communications limited

Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples…

SBS: 16th Annual conference and Exhibition

Issue 1 2010 / 22 February 2010 /

During this five day event, more than 2,000 scientists, innovators, researchers and industry analysts from around the world will converge in Phoenix to learn about the latest trends and basic and applied research that are transforming the way new pharmaceuticals are developed…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...